Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Lynch

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
South Dakota Medicine : the Journal of the South Dakota State Medical Association|March 10, 2023
Angioinvasive Fungal ThyroiditsAndrew Holmes, Brendan Wechsler, Douglas Lynch
South Dakota Medicine : the Journal of the South Dakota State Medical Association|July 14, 2018
Epstein-Barr Virus Positive Mucocutaneous Ulcer: A Case ReportVasantha Gali, Jonathan S Bleeker, Douglas Lynch
Haematologica|June 9, 2022
Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasiaNaseema Gangat, Jonathan Bleeker, Douglas Lynch, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 18, 2020
Extramedullary Myeloid Sarcoma with Symptoms of Acute Pancreatitis Mimicking Pancreatic CarcinomaSean Clausen, Mansi Oberoi, Douglas Lynch, et al.
Pediatric Blood & Cancer|September 12, 2020
Aggressive Langerhans cell histiocytosis following T-cell acute lymphoblastic leukemiaChandler Jansen, Jordan Dykstra, Daniel Callaway, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|March 28, 2014
Undifferentiated carcinoma of pancreas: a rare entity with aggressive behavior and possible genetic linkKabir Ahmed, Douglas Lynch, Kimberlee Tams, et al.
Journal of Graduate Medical Education|December 3, 2013
Defining scholarly activity in graduate medical educationErin C Grady, Adam Roise, Daniel Barr, et al.
Oncogene|April 10, 2023
UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancerSanam Sane, Rekha Srinivasan, Rashaun A Potts, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
South Dakota Medicine : the Journal of the South Dakota State Medical Association|March 10, 2023
Angioinvasive Fungal ThyroiditsAndrew Holmes, Brendan Wechsler, Douglas Lynch
South Dakota Medicine : the Journal of the South Dakota State Medical Association|July 14, 2018
Epstein-Barr Virus Positive Mucocutaneous Ulcer: A Case ReportVasantha Gali, Jonathan S Bleeker, Douglas Lynch
Haematologica|June 9, 2022
Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasiaNaseema Gangat, Jonathan Bleeker, Douglas Lynch, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 18, 2020
Extramedullary Myeloid Sarcoma with Symptoms of Acute Pancreatitis Mimicking Pancreatic CarcinomaSean Clausen, Mansi Oberoi, Douglas Lynch, et al.
Pediatric Blood & Cancer|September 12, 2020
Aggressive Langerhans cell histiocytosis following T-cell acute lymphoblastic leukemiaChandler Jansen, Jordan Dykstra, Daniel Callaway, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|March 28, 2014
Undifferentiated carcinoma of pancreas: a rare entity with aggressive behavior and possible genetic linkKabir Ahmed, Douglas Lynch, Kimberlee Tams, et al.
Journal of Graduate Medical Education|December 3, 2013
Defining scholarly activity in graduate medical educationErin C Grady, Adam Roise, Daniel Barr, et al.
Oncogene|April 10, 2023
UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancerSanam Sane, Rekha Srinivasan, Rashaun A Potts, et al.
Pageof 1